WaizelMRickmannABlankeBRWolfKKazerounianSSzurmanPResponse to bevacizumab after treatment with aflibercept in eyes with neovascular AMD. Eur J Ophthalmol2016 Apr 12:0. [Epub ahead of print].
2.
HatzKPrünteCTreat and Extend versus Pro Re Nata regimens of ranibizumab in neovascular age-related macular degeneration: a comparative 12 Month study. Acta Ophthalmol2016 Mar 24. [Epub ahead of print].
3.
Fassnacht-RiederleHBeckerMGrafNMichelsSEffect of aflibercept in insufficient responders to prior anti-VEGF therapy in neovascular AMD. Graefes Arch Clin Exp Ophthalmol2014; 252(11): 1705–1709
4.
BakallBFolkJCBoldtHCAflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Am J Ophthalmol2013; 156(1): 15–22.e1
5.
McCannelCAMeta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina2011; 31(4): 654–661
